Terbutaline sulphate

Newman, S.P., Moren, F., Trofast, E., Talaee, N., and Clarke, S.W., Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler, Eur. Resp. J., 2 247-252 (1989). 

S. Newman, K. Steed, G. Hooper, A. Kallen, and L. Borgstrom, Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler, Pharm. Res. 72 231 (1995). 

Flament, M. P, Leterme, R, and Gayot, A. (2004),The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers, Int. J. Pharm., 275,201-209. 

Infra-red Spectrum. Principal peaks at wavenumbers 1210,1231, 1155,1069,1610,1042 (terbutaline sulphate, KBrdisk). 

Inositol Nicotinate Terbutaline Sulphate Chlorhexidine Hydrochloride Naphazoline Hydrochloride Sulphadiazine Sulphasalazine Mepivacaine Hydrochloride Digitoxin... 

Borgstrom, L. Newman, S. Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via turbuhaler. Int. J. Pharm. 1993, 97, 47-53. 

Sharma P, Hamsa V. Formulation and evaluation of buccal mucoadhesive patches of terbutaline sulphate. STP Pharma Sci 2001 11 275-281. 

El-Gindy GA, Ali AS, El-Shinnawi OM. Preparation and formulation of sustained-release terbutaline sulphate microcapsules. Bull Pharm Sci Assiut XJniv 2000 23(1) 55-63. 

Newman S, Brown J, Steed K, Reader S, Kladders H. Lung deposition of budesonide inhaled via Turbuhaler a comparison with Terbutaline sulphate in normal subjects. Eur Respir, J 1998, 7, 69-73. 

Murthy, S.N. and Hiremath, R.R. (2001) Physical and chemical permeation enhancers in transdermal delivery of terbutaline sulphate . AAPS PharmSciTech. 2, 1-5. 

MT Ackermans, JL Beckers, FM Everaerts, IGJA Seleen. Comparison of isotacho-phoresis, capillary electrophoresis and high performance liquid chromatography for the determination of salbutamol, terbutaline sulphate and fenoterol hydrobromide in pharmaceutical dosage forms. J Chromatogr 590 341-353, 1992. 

Newton, D.W., Fung, E.Y.Y., and Williams, D.A. (1981) Stability of five catecholamines and terbutaline sulphate in 5% dextrose injection in the absence and presence of amino-pylline, Am. J. Hosp. Pharm., 38, 1314—1319. 

M. Strandberg and S. Thelander, A Microprocessor-Controlled Flow Injection Analyser for the Determination of Terbutaline Sulphate. Anal. Chim. Acta, 145 (1983) 219. 

Dolovich M., Vanziegelheim M, Hidinger K. Influence of inspiratory flow rate on the response to terbutaline sulphate inhaled via the Turbuhaler (abstr). Am Rev Respir Dis 1988 137 433. 

Hultquist C, WoUmr P, Eklund G, Jonson B. Effect of inhaled terbutaline sulphate in relation to its deposition in the lungs. Pulm Pharm 1992 5 127-132. 

Newman S, Moren F, Trofast E, Talaee N, Clarke S. Terbutaline sulphate Turbuhaler effect of inhaled flow rate on drug deposition and efficacy. Int J Pharm 1991 74 209-213. 

Terbutaline sulphate is a crystalline solid soluble at 2% w/v in water and 0.12% in ethanol. Typical preparations... 

Tablets 5 mg of terbutaline sulphate. Adult dose 2.5 mg to 5 mg 3x daily. 

---